Fidelity Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Sell |
1,461
-39
| -3% | -$3.43K | ﹤0.01% | 3489 |
|
|
2025
Q1 | $137K | Sell |
1,500
-473
| -24% | -$43.1K | ﹤0.01% | 3417 |
|
|
2024
Q4 | $170K | Buy |
1,973
+68
| +4% | +$5.87K | ﹤0.01% | 3330 |
|
|
2024
Q3 | $181K | Buy |
1,905
+212
| +13% | +$20.1K | ﹤0.01% | 3221 |
|
|
2024
Q2 | $155K | Buy |
1,693
+476
| +39% | +$43.5K | ﹤0.01% | 3116 |
|
|
2024
Q1 | $110K | Buy |
1,217
+985
| +425% | +$89.3K | ﹤0.01% | 3240 |
|
|
2023
Q4 | $18.9K | Buy |
232
+15
| +7% | +$1.22K | ﹤0.01% | 3973 |
|
|
2023
Q3 | $17.3K | Hold |
217
| – | – | ﹤0.01% | 3873 |
|
|
2023
Q2 | $17.1K | Hold |
217
| – | – | ﹤0.01% | 3930 |
|
|
2023
Q1 | $16.8K | Buy |
217
+51
| +31% | +$3.96K | ﹤0.01% | 3916 |
|
|
2022
Q4 | $12.9K | Sell |
166
-148
| -47% | -$11.5K | ﹤0.01% | 3923 |
|
|
2022
Q3 | $21K | Buy |
314
+23
| +8% | +$1.54K | ﹤0.01% | 3837 |
|
|
2022
Q2 | $22K | Buy |
291
+16
| +6% | +$1.21K | ﹤0.01% | 3846 |
|
|
2022
Q1 | $22K | Buy |
275
+75
| +38% | +$6K | ﹤0.01% | 3976 |
|
|
2021
Q4 | $15K | Hold |
200
| – | – | ﹤0.01% | 3538 |
|
|
2021
Q3 | $15K | Hold |
200
| – | – | ﹤0.01% | 3518 |
|
|
2021
Q2 | $15K | Hold |
200
| – | – | ﹤0.01% | 3456 |
|
|
2021
Q1 | $14K | Hold |
200
| – | – | ﹤0.01% | 3318 |
|
|
2020
Q4 | $13K | Hold |
200
| – | – | ﹤0.01% | 3262 |
|
|
2020
Q3 | $12K | Hold |
200
| – | – | ﹤0.01% | 3160 |
|
|
2020
Q2 | $12K | Sell |
200
-1
| -0.5% | -$60 | ﹤0.01% | 3082 |
|
|
2020
Q1 | $11K | Hold |
201
| – | – | ﹤0.01% | 3087 |
|
|
2019
Q4 | $13K | Buy |
201
+1
| +0.5% | +$65 | ﹤0.01% | 3209 |
|
|
2019
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 3215 |
|
|
2019
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 3200 |
|
|
2019
Q1 | $12K | Buy |
+200
| New | +$12K | ﹤0.01% | 3089 |
|